How do you bring together multiple operating companies to shape consistent and effective ways of engaging with patients?
This UK-based pharma company is active in more than 150 markets globally. Over the years, they had established mature practices for capturing and embedding patient insights and managing relationships with patient organisations. But they lacked a joined-up approach to applying these practices across their global business.
The company came to Baringa with an ambition to achieve greater consistency in the way they used patient insights throughout the product life cycle. The ultimate goal? To drive better decision-making and improve patient outcomes.
To turn their ambition into reality, we designed a new operating model, enabled by a central network of experts
We worked with the company’s global patient-focused development team to align on a purpose and vision for how they would deliver patient engagement and collaborate with patient organisations, all in line with their broader patient impact mission.
From this starting point, we defined a set of global ambitions. These underpinned what effective work with patients and patient organisations would mean operationally, from research through to development and go-to-market. We engaged both global teams and local markets to sharpen their focus on the new ambitions. We also drew on their expertise to better understand existing regulatory nuances, which could impact the effectiveness of driving real change.
Our next step was to partner with functional teams across the organisation to develop best-practice guides to align the entire business on what effective patient engagement looks like. We subsequently established a global patient advocacy and engagement network –
connecting specialists from across R&D, global functions and commercial business units to drive innovation and share advice, support and guidance.
Delivering better outcomes by understanding and sharing the real patient voice
The company now has a clear understanding of how to make positive and lasting change in the consistency and quality of its engagement with patients and patient organisations. Their newly established network of experts holds clear accountability for driving cultural change, supporting capability growth amongst members and acting as advocates for optimising patient insights across the organisation.
Their continued success will also be key to achieving the company’s 2023 global R&D cultural objective.
Find out how we help clients in Pharmaceuticals and Life Sciences
Related Case Studies
We talk with our client LifeArc about the challenges around operationalising patient centricity
We discuss patients and patient centricity, the difficulties around operationalising and the challenges of making a difference for patients.Read more
How Baringa supported medical research charity LifeArc with its transformation
Baringa Pharmaceuticals and Life Sciences partner Kate Moss talks to LifeArc CEO Dr Melanie Lee about transforming the charity and the legacy left behind.Read more
Helping a global biopharmaceutical company to simplify their clinical development processes
A global biopharmaceutical company asked us to create a set of clinical development processes which could be applied within their business divisionRead more
Delivering better outcomes for patients with smarter product development processes
A global biotech company asked us to help them achieve their vision of the future of medicine - connecting diagnosis, remote patient monitoring and medicines.Read more